NCT06458699

Brief Summary

Indications for jejunostomy, ileostomy or colostomy vary in the neonatal population. The most common etiologies are congenital anomalies, such as anorectal malformations, intestinal atresia or Hirschsprung's disease, but also acquired conditions, such as enterocolitis or intestinal perforation. The aim of these stomas is to divert stool in the event of intestinal obstruction or risk of fecal contamination. Depending on the indication and the type of stoma used, the post-operative follow-up, such as resumption of intestinal transit and feeding, secondary closure of the stoma or not, and the duration and cost of hospitalization differ. The aim of this study is to compare these differences in order to extract an optimal management strategy, in the light of what is reported in the international scientific literature.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 5, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 14, 2024

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

June 14, 2024

Status Verified

April 1, 2024

Enrollment Period

1 month

First QC Date

June 5, 2024

Last Update Submit

June 12, 2024

Conditions

Keywords

OstomyNeonateOutcomesCosts

Outcome Measures

Primary Outcomes (2)

  • Postoperative medical complications

    infections, sepsis, dehydration, hydroelectrolytic disorders

    through study completion, an average of 1 year

  • Postoperative surgical complications

    disunion, surgical scar,

    through study completion, an average of 1 year

Secondary Outcomes (2)

  • Length of stay

    through study completion, an average of 1 year

  • Hospitalization costs

    through study completion, an average of 1 year

Other Outcomes (1)

  • Redo

    through study completion, an average of 1 year

Study Arms (5)

Hirschsprung's Disease

Patients with Hirschsprung's Disease who had a stoma in the first 3 months of life

Anorectal MAlformations

Patients with Anorectal MAlformations who had a stoma in the first 3 months of life

Intestinal Atresia

Patients with Intestinal Atresia who had a stoma in the first 3 months of life

Necrotizing Enterocolitis

Patients with Necrotizing Enterocolitis who had a stoma in the first 3 months of life

Intestinal Perforations

Patients with Intestinal Perforations who had a stoma in the first 3 months of life

Eligibility Criteria

Age1 Minute - 3 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates whose disease require a stoma during the first 3 months of life, from January 2009 to December 2023

You may qualify if:

  • Patients who had a stoma during the first 3 months of life, from January 2009 to December 2023

You may not qualify if:

  • Patients who had a stoma after the first 3 months of life, from January 2009 to December 2023
  • Patients without a stoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clermont-Ferrand University Hospital

Clermont-Ferrand, Auvergne, 63000, France

Location

MeSH Terms

Conditions

Infant, Newborn, Diseases

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Christelle Destinval, MD

    University Hospital, Clermont-Ferrand

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2024

First Posted

June 14, 2024

Study Start

May 30, 2024

Primary Completion

June 30, 2024

Study Completion

July 15, 2024

Last Updated

June 14, 2024

Record last verified: 2024-04

Locations